SCHEMBL30936632

SCHEMBL30936632

CN(C(=O)OC(C)(C)C)c1c(F)cccc1[N+](=O)[O-]

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ALDH1A1 P00352 3/20 0.37
HTT P42858 1/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
GPR35 Q9HC97 1/20 0.36
TSHR P16473 1/20 0.35
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
HSPB1 P04792 1/20 0.35
NR1D1 P20393 2/20 0.34
MET P08581 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26426301 0.88 NPSR1 (0.39) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL30379982 0.88 NPSR1 (0.39) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL26090267 0.86 L3MBTL1 (0.38) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL31720604 0.85 TDP1 (0.46) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL23540991 0.84 NPSR1 (0.38) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL30936620 0.84 ALDH1A1 (0.44) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL30893303 0.84 NPSR1 (0.38) NPSR1L3MBTL1ALDH1A1HTTLMNA
SCHEMBL20045660 0.84 ALDH1A1 (0.34) NPSR1ALDH1A1HTTLMNAMEN1
SCHEMBL7476967 0.83 TSHR (0.50) NPSR1L3MBTL1ALDH1A1HTTMEN1
SCHEMBL30893241 0.82 MAPT (0.36) NPSR1ALDH1A1HTTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 NPSR1 680/4885L3MBTL1 2204/4885ALDH1A1 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.